AI for Lifelong Health: Why We Invested In Longevity AI

We are excited to announce our investment in Longevity AI, a groundbreaking B2B SaaS company at the forefront of the longevity and preventive healthcare space. Longevity AI has developed a powerful platform that transforms how longevity clinics operate, enabling them to scale more efficiently and deliver a higher quality of care. With a strong AI-driven platform, this company is poised to significantly impact the healthcare industry, and we believe it presents a unique opportunity for both financial growth and positive social impact.

Preventative Care is the Future

The global healthcare system is facing a critical challenge—an aging population and a rising prevalence of chronic diseases. Traditional medical practices tend to be reactive, focusing on treating diseases only once they manifest, often too late to reverse their effects. The growing demand for preventive care is evident, but there are significant barriers to its widespread adoption, such as high costs, limited insurance coverage, and a shortage of trained physicians. Longevity AI directly addresses these inefficiencies, creating a solution that not only empowers healthcare providers but also drives down costs, increases patient capacity, and enhances overall care quality.

Unmatched Data and AI engine

At the heart of Longevity AI’s value proposition is its comprehensive 360° Longevity Platform, powered by proprietary AI trained on an unparalleled dataset of medical records. This platform integrates seamlessly into existing healthcare workflows, offering clinics the ability to reduce administrative time by over 40%, thereby improving profitability and allowing them to potentially double their patient capacity. It also enhances patient outcomes by delivering highly personalized care plans that target chronic diseases before they manifest, improving long-term health spans.

One of the company’s standout features is its unmatched dataset, which includes 20 years of medical records for over 5 million lives in Israel and North America. This extremely rich, longitudinal data set, combined with AI-driven insights, allows Longevity AI to provide highly accurate risk assessments and actionable health recommendations. In an industry where precision is critical, this data-driven approach positions the company as a leader in preventive healthcare, and its ability to integrate seamlessly into clinical workflows makes it an attractive option for clinics seeking efficiency and scalability.

Gold-Standard Customers

Longevity AI’s initial traction has been impressive, securing partnerships with top-tier clinics such as Cenegenics, a leading concierge medical practice with over 25 locations across the US. Their strategic partnership with the American Medical Association (AMA) provides further validation of the platform’s ability to improve health outcomes and support reimbursement efforts.

All-Star Team

The team behind Longevity AI is another key reason for our investment. CEO Guy Leitersdorf, a former Head of AI at ironSource, brings a wealth of experience in building AI products at scale. He is supported by Executive Director Amihai Neiderman (Founder and Chairman of Nym Medical, another Kli Capital portfolio company), CTO Dor Daniel and COO Kayla Raizner. Together, Longevity AI’s leadership team is exceptionally capable. 

Looking ahead, we see significant potential for Longevity AI to capture a substantial share of the growing wellness market, which is valued at $480 billion in the US and $1.8 trillion globally. With an efficient, scalable platform and a proven ability to integrate into clinic workflows, we believe the company is well-positioned for rapid growth. Longevity AI is transforming the preventive healthcare landscape with its AI-powered platform that drives efficiency, improves patient outcomes, and makes personalized care more accessible. With strong market traction, an exceptional dataset, and a scalable business model, we are confident that Longevity AI will play a leading role in the future of healthcare. We’re proud to support them as they continue to innovate and scale in this exciting space.